Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast-Ovarian Cancer Syndrome?

By Goshen R.   Chu W.   Elit L.   Pal T.   Hakimi J.   Ackerman I.   Fyles A.   Mitchell M.   Narod S.A.  

Gynecologic Oncology, Vol. 79, Iss. 3, 2000-12 ,pp. : 477-481

Elsevier

Access to resources Recommend Favorite

Inguinal Lymph Node Metastasis as the Only Manifestation of Lymphatic Spread in Ovarian Cancer: A Case Report

By Scholz H.S.   Lax S.   Tamussino K.F.   Petru E.  

Gynecologic Oncology, Vol. 75, Iss. 3, 1999-12 ,pp. : 517-518

Elsevier

Access to resources Recommend Favorite

Hereditary Ovarian Cancer - Lessons from the First Twenty Years of the Gilda Radner Familial Ovarian Cancer Registry

By Piver M.S.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 9-17

Elsevier

Access to resources Recommend Favorite

Does Supportive Pamidronate Treatment Prevent or Delay the First Manifestation of Bone Metastases in Breast Cancer Patients?

By van Holten-Verzantvoort A.T.M.   Hermans J.   Beex L.V.A.M.   Blijham G.   Cleton F.J.   van Eck-Smit B.C.F.   Sleeboom H.P.   Papapoulos S.E.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 450-454

Elsevier

Access to resources Recommend Favorite

Hypersensitivity Reactions to Intraperitoneal Administration of Carboplatin in Ovarian Cancer: The First Report of a Case

By Shukunami K.-i.   Kurokawa T.   Kawakami Y.   Kubo M.   Kotsuji F.  

Gynecologic Oncology, Vol. 72, Iss. 3, 1999-03 ,pp. : 431-432

Elsevier

Access to resources Recommend Favorite